Sunshine Act Meeting, 31538-31539 [2021-12529]

Download as PDF 31538 Federal Register / Vol. 86, No. 112 / Monday, June 14, 2021 / Notices other activity for these drug codes is authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. William T. McDermott, Assistant Administrator. [FR Doc. 2021–12353 Filed 6–11–21; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–849] Controlled substance Drug code Schedule Marihuana Extract .... 7350 I The company plans to import the above controlled substance as finished dosage forms for clinical trials. No other activity for this drug code is authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. Importer of Controlled Substances Application: Fisher Clinical Services, Inc. William T. McDermott, Assistant Administrator. Drug Enforcement Administration, Justice. ACTION: Notice of application. BILLING CODE P AGENCY: Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before July 14, 2021. Such persons may also file a written request for a hearing on the application on or before July 14, 2021. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on May 17, 2021, Fisher Clinical Services, Inc., 700A–C Nestle Way, Breinigsville, Pennsylvania SUMMARY: lotter on DSK11XQN23PROD with NOTICES1 18031–1522, applied to be registered as an importer of the following basic class(es) of controlled substance(s): VerDate Sep<11>2014 17:26 Jun 11, 2021 Jkt 253001 [FR Doc. 2021–12350 Filed 6–11–21; 8:45 am] NATIONAL AERONAUTICS AND SPACE ADMINISTRATION [Notice: (21–037)] NASA Astrophysics Advisory Committee; Meeting National Aeronautics and Space Administration. ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, Public Law 92–463, as amended, the National Aeronautics and Space Administration (NASA) announces a meeting of the Astrophysics Advisory Committee. This Committee reports to the Director, Astrophysics Division, Science Mission Directorate, NASA Headquarters. The meeting will be held for the purpose of soliciting, from the scientific community and other persons, scientific and technical information relevant to program planning. DATES: Tuesday, June 29, 2021, 11:00 a.m.–5:00 p.m., Eastern Time; and Wednesday, June 30, 2021, 11:00 a.m.– 5:00 p.m., Eastern Time. FOR FURTHER INFORMATION CONTACT: Ms. KarShelia Henderson, Science Mission Directorate, NASA Headquarters, Washington, DC 20546, (202) 358–2355, or khenderson@nasa.gov. SUPPLEMENTARY INFORMATION: The meeting will be virtual and available to the public by WebEx and dial-in teleconference. On Tuesday, June 29, the event address for attendees is: SUMMARY: PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 https://nasaenterprise.webex.com/ nasaenterprise/j.php?MTID= m19281c9d7b875a40a767c1af1f5fd5d4, the meeting number is 199 024 6323, and meeting password is 2bkHspPS@65. On Wednesday, June 30, the event address for attendees is: https:// nasaenterprise.webex.com/ nasaenterprise/j.php?MTID= mc4d6d874b2e677b1e6460c8fb1b8df0a, the meeting number is 199 642 8616, and meeting password is XZgYwCr2@ 65. To join by telephone, the numbers are: 1–929–251–9612 or 1–415–527– 5035, for each day. The agenda for the meeting includes the following topics: —Astrophysics Division Update —Updates on Specific Astrophysics Missions —Reports from the Program Analysis Groups —Report on Science Activation Program The agenda will be posted on the Astrophysics Advisory Committee web page: https://science.nasa.gov/ researchers/nac/science-advisorycommittees/apac. The public may submit and upvote comments/questions ahead of the meeting through the website https:// arc.cnf.io/sessions/qgpt/#!/dashboard that will be opened for input on June 14, 2021. It is imperative that the meeting be held on this date to accommodate the scheduling priorities of the key participants. Patricia Rausch, Advisory Committee Management Officer, National Aeronautics and Space Administration. [FR Doc. 2021–12446 Filed 6–11–21; 8:45 am] BILLING CODE 7510–13–P NATIONAL SCIENCE FOUNDATION Sunshine Act Meeting The National Science Board’s ad hoc Committee on Nominating NSB Class of 2022–2028 (NOMS), hereby gives notice of the scheduling of a teleconference for the transaction of National Science Board business, as follows: TIME AND DATE: Thursday, June 17, 2021, from 11:30 a.m.–12:00 p.m. EDT. PLACE: This meeting will be held by teleconference through the National Science Foundation, 2415 Eisenhower Avenue, Alexandria, VA 22314. STATUS: Closed. MATTERS TO BE CONSIDERED: The agenda of the teleconference is: To review the master list of NSB Nominees, discuss review and rating guidance, and receive reviewing assignments. E:\FR\FM\14JNN1.SGM 14JNN1 Federal Register / Vol. 86, No. 112 / Monday, June 14, 2021 / Notices CONTACT PERSON FOR MORE INFORMATION: Point of contact for this meeting is: Chris Blair, cblair@nsf.gov, 703/292– 7000. Meeting information and updates may be found at https://www.nsf.gov/ nsb/meetings/notices.jsp#sunshine. Please refer to the National Science Board website www.nsf.gov/nsb for general information. Chris Blair, Executive Assistant to the National Science Board Office. [FR Doc. 2021–12529 Filed 6–11–21; 4:15 pm] BILLING CODE 7555–01–P NUCLEAR REGULATORY COMMISSION American Centrifuge Operating, LLC; American Centrifuge Plant Nuclear Regulatory Commission. ACTION: Environmental assessment and finding of no significant impact; issuance. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) is considering the amendment submitted by the American Centrifuge Operating, LLC (ACO) of Special Nuclear Materials (SNM) License SNM–2011 for the American Centrifuge Plant (ACP), a proposed commercial uranium enrichment facilty to be located in Piketon, Ohio. The NRC has prepared an environmental assessment (EA) for this proposed license amendment in accordance with its regulations. Based on the EA, the NRC has concluded that a finding of no significant impact (FONSI) is appropriate. The NRC is also conducting a safety evaluation of the proposed license amendment. DATES: The EA and FONSI referenced in this document are available on June 14, 2021. ADDRESSES: Please refer to Docket ID NRC–2021–0058 when contacting the NRC about the availability of information regarding this document. You may obtain publicly available information related to this document using any of the following methods: • Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC–2021–0058. Address questions about Docket IDs in Regulations.gov to Stacy Schumann; telephone: 301–415–0624; email: Stacy.Schumann@nrc.gov. For technical questions, contact the individual listed in the FOR FURTHER INFORMATION CONTACT section of this document. lotter on DSK11XQN23PROD with NOTICES1 SUMMARY: 17:26 Jun 11, 2021 Jean Trefethen, Office of Nuclear Material Safety and Safeguards, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001; telephone: 301–415– 0867; email: Jean.Trefethen@nrc.gov. FOR FURTHER INFORMATION CONTACT: [Docket No. 70–7003; NRC–2021–0058] VerDate Sep<11>2014 • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publicly available documents online in the ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/ adams.html. To begin the search, select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301– 415–4737, or by email to pdr.resource@ nrc.gov. The ADAMS accession number for each document referenced in this document (if that document is available in ADAMS) is provided the first time that a document is referenced. Jkt 253001 SUPPLEMENTARY INFORMATION: I. Introduction Frm 00063 Fmt 4703 II. Final Environmental Assessment Summary ACO is requesting an amendment to license SNM–2011 to authorize the enrichment of uranium-235 to the level necessary to produce HALEU in a demonstration cascade pursuant to a contract with DOE. The NRC has assessed the potential environmental impacts of the proposed action and the no-action alternative. The results of the NRC’s environmental review can be found in the final EA (ADAMS Accession No. ML21085A705). The NRC staff performed its environmental review in accordance with the requirements in 10 CFR part 51. In conducting the environmental review, the NRC considered information in the LAR; communications with the Ohio State Historic Preservation Office; as well as information provided by the Ohio Ecological Services Field Office of Fish and Wildlife, the Ohio Department of Health, and the Environmental Protection Agency Region V. III. Finding of No Significant Impact The NRC is considering a license amendment request (LAR) for license SNM–2011 for the ACP located on the U.S. Department of Energy (DOE) reservation in Piketon, Ohio (ADAMS Accession Nos. ML20139A097 and ML20139A098). The licensee, ACO, is requesting authorization to enrich uranium-235 up to the level necessary to produce High-Assay Low-Enriched Uranium (HALEU) pursuant to a contract with DOE. Under the 3-year term of the DOE contract, ACO would operate a cascade consisting of 16 centrifuges for the purpose of demonstrating the commercial viability of HALEU production for potential future use in advanced reactors. The NRC staff has prepared a final EA as part of its review of this LAR request in accordance with the requirements of Part 51 of title 10 of the Code of Federal Regulations (10 CFR), ‘‘Environmental Protection Regulations for Domestic Licensing and Related Regulatory Functions.’’ Based on the final EA, the NRC has determined that an environmental impact statement (EIS) is not required for this proposed action and a FONSI is appropriate. The NRC is also conducting a safety evaluation of the proposed license amendment pursuant to 10 CFR part 70, and the results will be documented in a separate Safety Evaluation Report (SER). If ACO’s request is approved, the NRC will issue the license amendment following publication of this final EA and FONSI and the SER in the Federal Register. PO 00000 31539 Sfmt 4703 Based on its review of the proposed action in the EA, in accordance with the requirements in 10 CFR part 51, the NRC has concluded that the proposed action, amendment of NRC license SNM–2011 for the American Centrifuge Co., LLC, located in Piketon, Ohio, will not significantly affect the quality of the human environment. Therefore, the NRC has determined, pursuant to 10 CFR 51.31, that preparation of an EIS is not required for the proposed action and a FONSI is appropriate. Dated: June 8, 2021. For the Nuclear Regulatory Commission. Stacey F. Imboden, Acting Chief, Environmental Review Materials Branch, Division of Rulemaking, Environment, and Financial Support, Office of Nuclear Material Safety and Safeguards. [FR Doc. 2021–12356 Filed 6–11–21; 8:45 am] BILLING CODE 7590–01–P PENSION BENEFIT GUARANTY CORPORATION Submission of Information Collection for OMB Review; Comment Request; Survey of Nonparticipating Single Premium Group Annuity Rates Pension Benefit Guaranty Corporation. ACTION: Notice of request for extension of OMB approval, with modifications. AGENCY: The Pension Benefit Guaranty Corporation (PBGC) is requesting that the Office of Management and Budget SUMMARY: E:\FR\FM\14JNN1.SGM 14JNN1

Agencies

[Federal Register Volume 86, Number 112 (Monday, June 14, 2021)]
[Notices]
[Pages 31538-31539]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-12529]


=======================================================================
-----------------------------------------------------------------------

NATIONAL SCIENCE FOUNDATION


Sunshine Act Meeting

    The National Science Board's ad hoc Committee on Nominating NSB 
Class of 2022-2028 (NOMS), hereby gives notice of the scheduling of a 
teleconference for the transaction of National Science Board business, 
as follows:

TIME AND DATE: Thursday, June 17, 2021, from 11:30 a.m.-12:00 p.m. EDT.

PLACE: This meeting will be held by teleconference through the National 
Science Foundation, 2415 Eisenhower Avenue, Alexandria, VA 22314.

STATUS: Closed.

MATTERS TO BE CONSIDERED: The agenda of the teleconference is: To 
review the master list of NSB Nominees, discuss review and rating 
guidance, and receive reviewing assignments.

[[Page 31539]]


CONTACT PERSON FOR MORE INFORMATION: Point of contact for this meeting 
is: Chris Blair, [email protected], 703/292-7000. Meeting information and 
updates may be found at https://www.nsf.gov/nsb/meetings/notices.jsp#sunshine. Please refer to the National Science Board 
website www.nsf.gov/nsb for general information.

Chris Blair,
Executive Assistant to the National Science Board Office.
[FR Doc. 2021-12529 Filed 6-11-21; 4:15 pm]
BILLING CODE 7555-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.